Compare Kyndryl Holdings Inc (KD) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kyndryl Holdings Inc vs Medtronic PLC — how do they compare? Kyndryl Holdings Inc trades at $11.75 (market cap $2.59B), while Medtronic PLC trades at $88.48 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 43.3× Kyndryl Holdings Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Kyndryl Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kyndryl Holdings Inc for 36 Days and Medtronic PLC for 63 Days on average.
| KD | MDT | |
|---|---|---|
Market Cap | $2.59B | $112.24B |
Volume | 5,354,348 | 105,663,236 |
Sector | Technology | Health |
52-Week High | $28.92 | $105.35 |
52-Week Low | $10.59 | $73.75 |
Typical Hold Time | 36 Days | 63 Days |
Enterprise Value | $5.41B | $131.58B |
Dividend Yield | — | 3.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kyndryl Holdings (KD) trades at $11.88, up 3.76% today, showing recent volatility amid mixed technical signals. The company reported positive net income of $252 million in 2025, marking a significant turnaround from prior losses, though revenue has declined from $18.3B in 2022 to $15.1B. Recent news highlights Kyndryl's strategic focus on AI, including the launch of an innovation lab and acquisition of Healthcare IT Leaders to drive growth.
Outlook remains cautious with analyst consensus leaning Hold (71% of ratings) and a $14.67 price target suggesting moderate upside. Key risks include declining revenue trends and competitive pressures in IT services, while opportunities lie in AI-driven modernization contracts and improved profitability. Investors should weigh the turnaround progress against execution risks in a challenging market.
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
